Polish court bans Krka's montelukast product
This article was originally published in Scrip
Executive Summary
Krka-Polskahas been temporarily prohibited from manufacturing, selling in Poland and exporting its anti-asthmatic Monkasta containing montelukast. A commercial court in Warsaw imposed the temporary injunction at the request of Merck & Co, whose product Singulair contains the same active ingredient.